Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Overview Microsoft Cloud Operations + Innovation (CO+I) is the engine that powers Microsoft’s cloud services. We deliver the core infrastructure and foundational technologies that support global services including Microsoft Azure, Microsoft 365, Bing, Xbox, and OneDrive.